Form 4: Invivyd CHRO Julie Green Reports RSU Vesting & Tax-Related Stock Sales

Invivyd's Chief Human Resources Officer, Julie Green, reported the vesting of 99,000 restricted stock units and subsequent sales of 40,627 shares to cover tax obligations.

Summary

• Julie Green, Invivyd's Chief Human Resources Officer, reported transactions related to her beneficial ownership.
• On February 15, 2026, 99,000 restricted stock units (RSUs) vested, converting into 99,000 shares of common stock.
• Following the vesting, Green sold 19,663 shares on February 17, 2026, at a weighted average price of $1.5396 per share.
• An additional 20,964 shares were sold on February 18, 2026, at a weighted average price of $1.5778 per share.
• These sales, totaling 40,627 shares, were non-discretionary "sell-to-cover" transactions executed under a Rule 10b5-1 plan adopted on February 20, 2025, to satisfy tax withholding obligations.
• After these transactions, Green beneficially owns 107,717 shares of common stock and 102,000 restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it represents a reduction in insider holdings, the sales are non-discretionary and for tax purposes, which is a routine aspect of executive compensation.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 plan, indicating planned rather than discretionary sales.
• The vesting of 99,000 RSUs demonstrates the company's compensation structure and employee retention mechanisms.

Negatives

• A total of 40,627 shares were sold by a key executive, reducing insider ownership.

Future Outlook

No specific forward-looking statements or guidance provided in this Form 4.

Industry Context

StockSavvy.ai notes that 'sell-to-cover' transactions are a common practice for executives to manage tax liabilities arising from equity compensation vesting. The use of a Rule 10b5-1 plan indicates a pre-scheduled, non-discretionary sale, which typically mitigates concerns about opportunistic insider trading.

Comparison to Industry Standards

• Form 4 filings are standard regulatory disclosures for insider transactions.
• The 'sell-to-cover' mechanism is a widely accepted practice across industries for managing executive equity compensation, similar to practices seen at companies like Pfizer or Moderna when their executives' stock options or RSUs vest.

Stakeholder Impact

• Shareholders: A slight reduction in insider ownership, but the non-discretionary nature of the sales under a 10b5-1 plan typically minimizes negative sentiment.
• Employees: The vesting of RSUs demonstrates the company's equity compensation program, which can be a positive for employee retention and motivation.

Next Steps

• Remaining 102,000 Restricted Stock Units will continue to vest over an eighteen-month period, with one-third vesting every six months following the grant date of February 15, 2025, subject to continuous service.

Key Dates

Recommendation

The filing details routine, non-discretionary insider sales for tax purposes following RSU vesting. These transactions are expected and do not reflect a change in management's outlook or a discretionary decision to reduce exposure to the company's stock. Therefore, it provides no new fundamental information to alter an existing investment thesis, warranting a 'hold' recommendation.

Keywords

Invivyd, IVVD, Julie Green, Form 4, Insider Trading, Restricted Stock Units, RSU, Stock Sales, Tax Withholding, Rule 10b5-1, Executive Compensation, Beneficial Ownership